Sunflower Pharmaceutical Group Co., Ltd.

¥12.07As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002737Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (0.28%)
Div yield 1.66%
ROE (3.85%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.21
PE TTM —
TSR TTM (16.11%)
Mkt cap ¥7.049B
ROIC (11.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
11.48%
(81.10%)
Hold 7|12|6|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.13
0.14
0.14
18.36%
13.99%
13.63%
17.78%
Revenue¥M
747.7
738.5
733.0
722.5
3.27%
(0.93%)
(1.68%)
(3.86%)
Peers (US$1.057B)
Cap (US$)
PE
1.068B
106.9x
1.064B
18.96x
1.061B
18.62x
1.045B
—
Capital
TTM
5Y
10Y
Leveragex
0.707
0.087
0.101
EBIT/Intx
1.947
0.131
0.121
Own earn%
(191.84)
112.05
111.92
Sh yield%
16.67
25.89
25.86
Owners
Insiders/Inst%
6.39
73.76
Short interest%
2.45
SBC / revenue%
5.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
5–13
$1 testx
—
Incr. ROIC%
2